Investing.com -- Biovie Inc (NASDAQ:BIVI)股价跳涨7.3%,此前该公司在罗马举行的会议上展示了其阿尔茨海默病药物bezisterim的有希望数据。 这家临床阶段生物技术公司揭示,在其三期研究中,与安慰剂相比,bezisterim在阿尔茨海默病患者中显示出显著的生物学年龄减缓效果。经过30周的治疗,接受该药物的患者在测量的各种生物钟上经历了高达4.24年的...
Source LinkInvesting.com -- Biovie Inc (NASDAQ:BIVI)股价跳涨7.3%,此前该公司在罗马举行的会议上展示了其阿尔茨海默病药物bezisterim的有希望数据。 这家临床阶段生物技术公司揭示,在其三期研究中,与安慰剂相比,bezisterim在阿尔茨海默病患者中显示出显著的生物学年龄减缓效果。经过30周的治疗,接受该药物的患者在测量的各种生物钟上经历了高达4.24年的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.